Links with the European Strategy Forum on Research Infrastructures (ESFRIs) will be reinforced in order to strengthen the European Research Area (ERA) in proteomics. Primary targets are the ESFRI infrastructures in the Biomedical and Life Sciences (BMS infrastructures). Some of these ESFRIs include those listed.



The ELIXIR Proteomics Community  ( is strongly represented by EPIC-XS consortium members. In fact, this bioinformatic proteomics community is led by EPIC-XS partners Juan Antonio Vizcaino (proteomics Team Leader at the EMBL-European Bioinformatics Institute, UK) Oliver Kohlbacher (Eberhard Karl’s University Tübingen, Germany), Lennart Martens (VIB, Ghent).



EOSC-Life is the new cluster project of the European life science RIs within the European Open Science Cloud (EOSC), aiming at creating an open collaborative space for digital biology in Europe. There is a very strong link between proteomics bioinformatics with the ELIXIR ESFRI project.



The EU OPenscreen consortium has 24 partners sites in 22 European locations of which EPIC-XS partners UiB are members. The goal of this EU-funded project is involved in processing the discovery of biologically active substances in all areas of the life sciences by providing open access to its shared resources to researchers from academic institutions, SME’s and industrial organizations.


Euro BioImaging

Euro-BioImaging is the European landmark research infrastructure for biological and biomedical imaging as recognized by the European Strategy Forum on Research Infrastructures (ESFRI). Through Euro-BioImaging, life scientists can access imaging instruments, expertise, training opportunities, and data management services that they might not find at their home institutions or among their collaboration partners.

This project is coordinated by a Hub and offers its services via 21 internationally renowned imaging facilities called Nodes, which are located across 8 countries, and the European Molecular Biology Laboratory, EMBL.



The European Advanced InfraStructure for Innovative Genomics (EASI GENOMICS) is funded under the European Union’s research and innovation programme Horizon 2020 and will provide researchers free-of-charge access to cutting-edge European genomics facilities. EASI-Genomics joins 16 academic and industrial partners to support diverse genomics projects from study design, through state-of-the-art sequencing to bioinformatics analysis.